Pro InterviewCEU SeminarSST/Sho-saiko-toOrder Info  Honso Seminar 2006

 
 

Honso’s GMP pharmaceutical facilities in Japan offer unrivaled high standards, from selection of the highest grade materials to perfection of proprietary processing techniques that ensure maximum quality, efficacy and safety.  Every lot of the Honso® Kampo product is routinely tested by its Quality Control Department.  They are tested for heavy metals, purity, and microbial content to eliminate any contaminant.  Most important of all, Honso tests the levels of key chemical constituents of at least two marker herbs by HPLC for quality control on every formula.  This is carried out from the blending of the raw herbs to the end product according to the Ministry’s pharmaceutical standards.  This is the most rigorous way to maintain consistency of quality from batch to batch each time.

In year 2002, Honso USA revealed its professional Kampo herbal formulas to licensed healthcare professionals. These products have been used by Japanese physicians under prescription for many decades. The formulations introduced are the most popular ones, including sho-saiko-to (H09), which is undergoing clinical phase II trials under two IND's from the Food and Drug Administration (FDA) for treating hepatitis C in New York and liver cirrhosis caused by hepatitis C in San Diego. The pharmaceutical grade quality, unique packaging, strong research and the exclusivity for licensed practitioners make this product line a right choice for all healthcare specialties.

Japanese Kampo is a unique approach to the ancient art of Chinese medicine. Most of the Kampo formulas were adopted from classical Chinese medicine of the Han Dynasty.  Rather than modifying formulas as in TCM, the Japanese Kampo tradition uses fixed and precise combinations of herbs in standardized amounts according to the classical literature of Chinese medicine.  Extensive modern scientific research in Japan has validated the efficacy of Kampo formulas.  Since 1967, the Japanese Ministry of Health, Labour and Welfare (the same central government body as the US FDA that regulates pharmaceutical manufacturers) has approved 148 Kampo formulas for coverage and reimbursement in the national health insurance plan.  Every approved formula produced by different manufacturers is composed of exactly the same ingredients under the Ministry’s standardization methodology.  Today, fully 75% of Japanese physicians prescribe Kampo formulas.

At Honso, we take science and quality as seriously as you do. We share your interest in having the highest quality Oriental herbal formulas available and we take your concerns about safety and purity very seriously. With 30 years experience in serving the Japanese medical community with premium-quality Kampo products, Honso is making a long-term commitment to complementary and alternative medicine practitioners in the world.

Join the Honso USA, Inc. mailing list
Email:

Professor Boxiang Wang, China's leading liver disease expert to co-present with Dr. Dan Wen on Treating Chronic Liver Disease with TCM at the Building Bridges of Integration Conference, New Jersey, Oct 6-8. More....

Honso to License Sho-saiko-to’s Marketing Right to HepCare, Inc.: A Clinical Proven Herbal Remedy for Liver Support in Capsules More...

Clinical Phase II Trial of Honso® Sho-saiko-to (H09) Continues to Report Data at the 2nd Society of Integrative Oncology Conference. More...

Acupuncture Today Publishes Dr. Dan Wen's Article about the Second International Science and Technology Conference on Traditional Chinese Medicine in Chengdu China. More...

Softgel Technology Arrives: Honso USA, Inc. Partners with Kanion Pharmaceutical Co., Ltd., to Launch New TCM Softgel Products. More...

Juzen-taiho-to or "Shi Quan Da Bu Tang", ameliorates anemia caused by interferon plus ribavirin  therapy in hepatitis C patients. More...

The Second Clinical Trial of Honso® Sho-saiko-to (H09) on Patients with Liver Cirrhosis Caused by Hepatitis C Begins at USCD Liver Center. More...

Acupuncture Today, the leading magazine for acupuncture and Chinese medicine practitioners, published an interview with Dr. Dan Wen of Honso USA on issue of ephedra ban by FDA. More...

Complementary Medicine: The Yin and the Yang: Two Party System for Healing, Alan Glombicki, MD., University of Texas

Kampo News March 2004 is available. More...

A review paper of treatment of chronic liver disease with sho-saiko-to by Dr. Dan Wen was published by the Oriental Medicine Journal. Click here to download this in-depth review.

New study shows Oren-Gedoku-To (Huanglian Jie Du Tang) protected red blood cell membrane from free radical attack. More...

Shakuyaku-kanzo-to (Shao yao gan cao tang) reduces muscle cramps in maintenance hemodialysis patients. More...

A novel anti-dysmenorrhea therapy with cyclic administration of two Kampo formulas (Shakuyaku-kanzo-to and Toki-shakuyaku-san) shows efficacies on 17 dysmenorrhea patients.  More...

The Special Edition of Kampo News on Liver Health is available for healthcare professionals, side effect and contraindication of Sho-saiko-to discussed. More...

Detail revealed by the National Institute of Health through its website ClinicalTrials.gov on the first "Sho-saiko-to" clinical phase II trial at the Sloan-Kettering Cancer Center. More...

Health Sciences Institute Member Alarm: Japanese medical system, once forced undergrand, may hold the secret to a longer, healthier life.  More...

 
 

 
 
4602 E Elwood Street, Suite 6, Phoenix, AZ 85040
Phone: 480-377-8787 or 888-461-5808
Fax: 480-377-6649; Email: info@honso.com
 
 

Copyright © Honso USA, Inc. Honso® and Honso Kampo® are registered trademarks of Honso USA, Inc.